| podofilox 0.5 % Topical Solution |
PSN |
| podofilox 0.5 % Topical Solution |
SY |
| podofilox 5 MG/ML Topical Solution |
SCD |
| podofilox 5 MG/ML Topical Solution |
SCD |
| podofilox 5 MG/ML Topical Solution |
SCD |
| podofilox 5 MG/ML Topical Solution |
SCD |
| podophyllotoxin 0.5 % Topical Gel |
SY |
| podophyllotoxin 0.5 % Topical Gel |
SY |
| POKONZA 0.75 GM Powder for Oral Solution |
PSN |
| Pokonza 10 MEQ (0.75 GM) Powder for Oral Solution |
SY |
| Polar Frost 0.04 MG/MG Topical Gel |
SY |
| Polar Frost 4 % Topical Gel |
SY |
| POLAR FROST 4 % Topical Gel |
PSN |
| polatuzumab vedotin-piiq 140 MG Injection |
PSN |
| polatuzumab vedotin-piiq 140 MG Injection |
SCD |
| polatuzumab vedotin-piiq 140 MG Injection [Polivy] |
SBD |
| polatuzumab vedotin-piiq 30 MG Injection |
SCD |
| polatuzumab vedotin-piiq 30 MG Injection [Polivy] |
SBD |
| polidocanol 0.5 % Injection |
SY |
| polidocanol 1 % Injectable Foam |
SY |
| polidocanol 1 % Injection |
SY |
| polidocanol 10 MG in 2 ML Injection |
PSN |
| polidocanol 10 MG per 2 ML Injection |
SY |
| polidocanol 10 MG/ML Injectable Foam |
SCD |
| polidocanol 10 MG/ML Injectable Foam [Varithena] |
SBD |
| polidocanol 180 MG in 18 ML Injectable Foam |
PSN |
| polidocanol 180 MG per 18 ML Injectable Foam |
SY |
| polidocanol 20 MG in 2 ML Injection |
PSN |
| polidocanol 20 MG per 2 ML Injection |
SY |
| poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML per 0.5 ML Injectable Suspension |
SY |